Road map for addressing ethical concerns tied to research on human-animal embryos

August 30, 2016

A new bioethical framework for addressing concerns surrounding potentially revolutionary research on human-animal embryos is publishing on Aug. 30, 2016 in the open-access journal PLOS Biology.

Human-animal embryos, called chimeras, can be produced when human stem cells are transplanted into animal embryos. By creating these types of embryos scientists could potentially grow human organs in large animals, such as pigs and sheep, to help ease the chronic shortage of human organs available for transplantation. This research could also be used to study the causes of many human diseases. But the use of the human cells in this work is controversial and last September, the National Institutes of Health imposed a moratorium on funding the research in response to ethical concerns (private funding was unaffected). Then, in early August, the NIH announced plans to lift the moratorium after a 30-day comment period on proposed regulations that require heightened review of the research under certain conditions.

In the PLOS Biology opinion piece, Insoo Hyun, PhD, associate professor of bioethics at the School of Medicine of Case Western Reserve University, argues that most, if not all, concerns tied to such research can be reasonably addressed in a way that prioritizes animal welfare while enabling scientific progress to help patients who need organ transplants.

While some researchers and bioethicists worry that a developing animal with a human organ could attain something like human moral status, especially if the central nervous system is involved, Hyun argues that these concerns -- while understandable -- are overstated. The appearance of human-like self-consciousness is needed to elevate the moral status of a research animal, but this distinctive psychological characteristic is not likely to emerge in a chimeric animal's brain, Hyun says. Instead, the much more likely outcome of neurological chimerism is an increased chance of animal suffering and biological dysfunction and disequilibrium, if past experience with transgenic animals can serve as a guide. "This is why," says Hyun, "focusing on animal welfare principles is crucial."

Hyun's arguments reflect the ethical standards for chimera research established by the Ethics and Public Policy Committee of the International Society for Stem Cell Research, which he helped develop.
-end-
In your coverage please use this URL to provide access to the freely available article in PLOS Biology: http://dx.doi.org/10.1371/journal.pbio.1002535

Citation: Hyun I (2016) What's Wrong with Human/Nonhuman Chimera Research? PLoS Biol 14(8): e1002535. doi:10.1371/journal.pbio.1002535

Funding: The author received no specific funding for this work.

Competing Interests: The authors have declared that no competing interests exist.

PLOS

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.